619 filings
Page 7 of 31
S-8
xqym94c2u5u5pwv0o9e3
25 Jun 18
Registration of securities for employees
4:31pm
8-K
toh89dpq42x3aum6
20 Jun 18
Entry into a Material Definitive Agreement
8:00am
8-K
heut4eal
18 Jun 18
Other Events
4:30pm
8-K
9c4b7nrw
15 Jun 18
TG Therapeutics, Inc. Announces Clinical and Preclinical Data Presentations at the 23rd Congress of the European Hematology Association
12:00am
8-K
8vp9axchqchus2yi
13 Jun 18
Submission of Matters to a Vote of Security Holders
12:00am
8-K
9bwugyac
7 Jun 18
Other Events
4:30pm
8-K
rx05lotb
4 Jun 18
TG Therapeutics, Inc. Announces Umbralisib Clinical Data Presentation at the 54th Annual Meeting of the American Society of Clinical Oncology
12:00am
8-K
zp202k05ru f9kxm6n
8 May 18
TG Therapeutics, Inc. Provides Business Update and Reports First Quarter 2018 Financial Results
7:37am
DEFA14A
lkxlgzxfdjzjplxi
30 Apr 18
Additional proxy soliciting materials
4:01pm
CT ORDER
awapra9j47eqrdgim
30 Apr 18
Confidential treatment order
12:00am
8-K
xnqhe zmalwyynm
24 Apr 18
Data on now up to 48 patients through 24 weeks confirms previously reported positive results
12:00am
8-K
xti 4zmnexe8n8sv9
8 Mar 18
TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2017 Financial Results and Business Update
12:00am
8-K
mqcc qm5sid1tamrkq
2 Feb 18
Other Events
12:00am
8-K
sy64yqvlnp8j
8 Jan 18
Entry into a Material Definitive Agreement
12:00am
8-K
urupfb98 obg2851opu
11 Dec 17
TG Therapeutics, Inc. Announces Preclinical & Clinical Data Presentations at the 59h American Society of Hematology Annual Meeting
12:00am